Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure

By Mandeep R. Mehra, D. Goldstein, N. Uriel, J. Cleveland, M. Yuzefpolskaya, C. Salerno, M. Walsh, C. Milano, C. Patel, G. Ewald and 18 more. New England Journal of Medicine, 2018

616 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Epidemiology, Surgery

View Paper: https://www.semanticscholar.org/paper/1cc84846f38bbebcb3d5715be74525a113ebe67b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Gerasimos Filippatos
2. L. Lund
3. D. Miličić
4. M. Costanzo
5. M. Frigerio
6. F. Gustafsson
7. J. Bauersachs
8. P. Seferovic

Citations in the corpus

• Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology (2018, background): “rates of reoperation to replacement or removal a malfunctioning device, and disabling strokes, although the incidence of other adverse events is similar between newer and older devices.(258) Particular concern exists with stroke rates, especially with the HVAD device (29% at 2 years), and the HeartM”